Influence of beta2 agonism and beta1 and beta2 antagonism on adverse effects and plasma lipoproteins: Results of a multicenter comparison of dilevalol and metoprolol
- 1 June 1989
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 63 (19) , I58-I63
- https://doi.org/10.1016/0002-9149(89)90131-8
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Dilevalol compared with propranolol and placebo for systemic hypertensionThe American Journal of Cardiology, 1989
- Mechanism of antihypertensive action of dilevalol compared with that of “cardioselective” beta-blocking agentsThe American Journal of Cardiology, 1989
- Multicenter Comparison of Dilevalol to Placebo in Patients with Mild HypertensionAmerican Journal of Hypertension, 1988
- Pharmacokinetics and Bioavailability of Dilevalol in Normotensive VolunteersThe Journal of Clinical Pharmacology, 1988
- Effects of the Antihypertensive Dilevalol on Aortic Compliance in Anesthetized DogsJournal of Cardiovascular Pharmacology, 1988
- Renal function effects of dilevalol, a nonselective beta-adrenergic blocking drug with beta-2 agonist activityClinical Pharmacology & Therapeutics, 1988
- A population at risk: Prevalence of high cholesterol levels in hypertensive patients in the framingham studyThe American Journal of Medicine, 1986
- Effect of beta blockers on blood lipid profileAmerican Heart Journal, 1985
- Synthesis and comparison of some cardiovascular properties of the stereoisomers of labetalolJournal of Medicinal Chemistry, 1982
- Studies on the Mechanism of the Acute Antihypertensive and Vasodilator Actions of Several β-Adrenoceptor AntagonistsJournal of Cardiovascular Pharmacology, 1982